Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial
Posted On Tuesday, March 25, 2025
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)
Posted On Tuesday, March 25, 2025
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
Posted On Tuesday, March 25, 2025
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians
Posted On Tuesday, March 25, 2025
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
Posted On Tuesday, March 25, 2025
Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan
Posted On Tuesday, March 25, 2025
Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
Posted On Monday, March 24, 2025
Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Posted On Monday, March 24, 2025
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Posted On Monday, March 24, 2025
AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Posted On Monday, March 24, 2025
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Posted On Monday, March 24, 2025
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Posted On Monday, March 24, 2025
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Posted On Monday, March 24, 2025
Abinopharm, Inc. warmly congratulates partner company EGT Synbio on receiving no objection letter from the FDA for their GRAS notification of Dr.Ergo®Ergothioneine
Posted On Monday, March 24, 2025
Provadent: The Science-Backed Supplement for Stronger Teeth & Gums
Posted On Monday, March 24, 2025
Better Choice Announces SRx Health’s Participation at the 2025 Bloom Burton & Co. Healthcare Investor Conference on May 5th and 6th
Posted On Monday, March 24, 2025
Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting
Posted On Monday, March 24, 2025
Anaptys Announces Stock Repurchase Plan
Posted On Monday, March 24, 2025
PharmAla Contracts with Partner to Act as US Distributor
Posted On Monday, March 24, 2025
PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners
Posted On Monday, March 24, 2025
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
Posted On Monday, March 24, 2025
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort
Posted On Monday, March 24, 2025
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
Posted On Monday, March 24, 2025
Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea
Posted On Monday, March 24, 2025
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose
Posted On Monday, March 24, 2025

Print